Prepregnancy Body Mass Index and Congenital Heart Defects among Offspring: A Population-based Study

Congenital Heart Disease

Volumn 8, Issue 2, 2013, Pages 131-141

  Madsen, Nicolas L ^a   Schwartz, Stephen M ^b   Lewin, Mark B ^a   Mueller, Beth A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Congenital Heart Defects; Maternal Risk Factors; Obesity

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS DEVELOPMENT; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HOSPITAL DISCHARGE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; ICD-9; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL OBESITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROGENY;

ADOLESCENT; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MOTHERS; OBESITY; ODDS RATIO; PATIENT DISCHARGE; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WASHINGTON; YOUNG ADULT;

EID: 84875871819     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00714.x     Document Type: Article

References (50)

1. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301:636-650.
2. UK Eurocat Central Registry. Prevalence Data Tables 1980-2005. Available at: http://www.eurocat.ulster.ac.uk. Accessed September 1, 2012.
3. Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics. 2001;107:E32.
4. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-1900.
5. Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J. 2004;147:425-439.
6. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ. 2009;338:b1673.
7. Jenkins KJ, Correa A, Feinstein JA, etal. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115:2995-3014.
8. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163-172.
9. Dadvand P, Rankin J, Shirley MD, Rushton S, Pless-Mulloli T. Descriptive epidemiology of congenital heart disease in northern england. Paediatr Perinat Epidemiol. 2009;23:58-65.
10. Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med. 2008;162:969-974.
11. Connor JA, Gauvreau K, Jenkins KJ. Factors associated with increased resource utilization for congenital heart disease. Pediatrics. 2005;116:689-695.
12. Fulton DR. Congenital heart disease in children and adolescents and Congenital heart disease in adults". In: Fuster V, O'Rourke RA, Walsh RA, etal., eds. Hurst's the Heart, 12th edn. New York: McGraw-Hill Companies, Inc.; 2008:546-556.
13. Uzark K, Jones K, Slusher J, Limbers CA, Burwinkle TM, Varni JW. Quality of life in children with heart disease as perceived by children and parents. Pediatrics. 2008;121:e1060-e1067.
14. Thienpont B, Mertens L, de Ravel T, etal. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J. 2007;28:2778-2784.
15. Pierpont ME, Basson CT, Benson DW Jr, etal. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the american heart association congenital cardiac defects committee, council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115:3015-3038.
16. Malik S, Schecter A, Caughy M, Fixler DE. Effect of proximity to hazardous waste sites on the development of congenital heart disease. Arch Environ Health. 2004;59:177-181.
17. Kuehn CM, Mueller BA, Checkoway H, Williams M. Risk of malformations associated with residential proximity to hazardous waste sites in Washington state. Environ Res. 2007;103:405-412.
18. Waller DK, Shaw GM, Rasmussen SA, etal. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007;161:745-750.
19. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003;111:1152-1158.
20. Yazdy MM, Liu S, Mitchell AA, Werler MM. Maternal dietary glycemic intake and the risk of neural tube defects. Am J Epidemiol. 2010;171:407-414.
21. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol. 2008;198:611-619.
22. Cedergren MI, Kallen BA. Maternal obesity and infant heart defects. Obes Res. 2003;11:1065-1071.
23. Gilboa SM, Correa A, Botto LD, etal.; The National Birth Defects Prevention Study. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol. 2010;202:51 e1-51 e10.
24. Mills JL, Troendle J, Conley MR, Carter T, Druschel CM. Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr. 2010;91:1543-1549.
25. Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J. Prepregnancy obesity and fetal death: a study within the Danish national birth cohort. Obstet Gynecol. 2005;106:250-259.
26. Riehle-Colarusso T, Strickland MJ, Reller MD, etal. Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol. 2007;79:743-753.
27. Strickland MJ, Riehle-Colarusso TJ, Jacobs JP, etal. The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young. 2008;18(suppl 2):92-100.
28. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A, National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007;79:714-727.
29. Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J. 2009;157:467-473.
30. Ossiander EM, Emanuel I, O'brien W, Malone K. Driver's licenses as a source of data on height and weight. Econ Hum Biol. 2004;2:219-227.
31. Macintosh MC, Fleming KM, Bailey JA, etal. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177-182.
32. American Academy of Pediatrics. Noninherited risk factors and congenital cardiovascular defects: current knowledge. Pediatrics. 2007;120:445-446.
33. Materna-Kiryluk A, Wisniewska K, Badura-Stronka M, etal. Parental age as a risk factor for isolated congenital malformations in a Polish population. Paediatr Perinat Epidemiol. 2009;23:29-40.
34. Batra M, Heike CL, Phillips RC, Weiss NS. Geographic and occupational risk factors for ventricular septal defects: Washington State, 1987-2003. Arch Pediatr Adolesc Med. 2007;161:89-95.
35. Kallen K. Maternal smoking and congenital heart defects. Eur J Epidemiol. 1999;15:731-737.
36. Malik S, Cleves MA, Honein MA, etal. Maternal smoking and congenital heart defects. Pediatrics. 2008;121:e810-e816.
37. Watkins And ML, Botto LD. Maternal prepregnancy weight and congenital heart defects in the offspring. Epidemiology. 2001;11:439-446.
38. Washington State Department of Health. Behavioral Risk Factor Surveillance System Survey. Available at: http://www.doh.wa.gov/CFH/NutritionPA/facts_and_figures/obesity_rates_wa/default.htm. Accessed September 1, 2009.
39. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-241.
40. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 2000.
41. Chappell JH Jr, Wang XD, Loeken MR. Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis. 2009;14:1472-1483.
42. Morgan SC, Relaix F, Sandell LL, Loeken MR. Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects. Birth Defects Res A Clin Mol Teratol. 2008;82:453-463.
43. Roest PA, van Iperen L, Vis S, etal. Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteine. Birth Defects Res A Clin Mol Teratol. 2007;79:231-235.
44. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes. 1999;48:2454-2462.
45. Hendricks KA, Nuno OM, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 2001;12:630-635.
46. Herring SJ, Oken E, Rifas-Shiman SL, etal. Weight gain in pregnancy and risk of maternal hyperglycemia. Am J Obstet Gynecol. 2009;201:61.e1-61.e7.
47. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, etal. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
48. Hotzel D. Suboptimal nutritional status in obesity (selected nutrients). Bibl Nutr Dieta. 1986;37:36-41.
49. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA. 1996;275:1093-1096.
50. Hobbs CA, Cleves MA, Karim MA, Zhao W, MacLeod SL. Maternal folate-related gene environment interactions and congenital heart defects. Obstet Gynecol. 2010;116:316-322.